Effect of renal replacement therapy on respiratory function of ARDS patients with AKI

Effect of renal replacement therapy on respiratory function of ARDS patients with AKI: protocol for a prospective, multicenter, cohort study

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000037641

Enrollment

Unknown

Registered

2020-08-29

Start date

2021-01-01

Completion date

Unknown

Last updated

2020-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ARDS with AKI

Interventions

RRT versus None-RRT:renal replace therapy (RRT) versus None-RRT

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients will be eligible for study inclusion if they are aged at least 18 years old, admitted to the ICU from January 1st, 2021 through December 31st, 2021, and diagnosed with ARDS and AKI.

Exclusion criteria

Exclusion criteria: Patients will be excluded for any of the following reasons or conditions: no informed consent, end-stage renal disease or those who receive renal replacement therapy before ICU admission, not expected to live greater than 48 hours, known pregnancy, and chronic pulmonary disease.

Design outcomes

Primary

Measure	Time frame
ventilator-free days during the first 28 days;	—

Secondary

Measure	Time frame
ICU mortality;hospital mortality;28-day mortality;ICU length of stay;hospital length of stay;time to resolution of ARDS;the proportion of successful extubation during the first 28 days;	—

Countries

China

Contacts

Public ContactXuan Song

Liaocheng Cardiac Hospital

songxuan0303@163.com+86 17806359196

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026